Mankind Pharma Limited — Updates, 18-03-2026: Press Release
18-03-2026 | 10:00 am
18-03-2026 | 10:00 am
Mankind Pharma acquired the Rivotril brand from Roche for India, securing exclusive manufacturing, marketing, and distribution rights. This strategic move strengthens Mankind's focus on chronic CNS therapies, expanding its neuro portfolio and leveraging its extensive distribution network to boost market presence.
No comments yet. Be the first to comment!
